To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.

This bill provides for approval of the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides.

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2855 Introduced in House (IH)]

<DOC>






116th CONGRESS
  1st Session
                                H. R. 2855

To deem the application submitted by Jaci Hermstad to the Food and Drug 
  Administration for compassionate use of the gene therapy antisense 
                    oligonucleotides to be approved.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 20, 2019

 Mr. King of Iowa introduced the following bill; which was referred to 
                  the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To deem the application submitted by Jaci Hermstad to the Food and Drug 
  Administration for compassionate use of the gene therapy antisense 
                    oligonucleotides to be approved.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DEEMED APPROVAL OF APPLICATION FOR COMPASSIONATE USE OF THE 
              GENE THERAPY ANTISENSE OLIGONUCLEOTIDES.

    Notwithstanding the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
301 et seq.) or any other provision of law, the application submitted 
by Jaci Hermstad to the Food and Drug Administration for compassionate 
use of the gene therapy antisense oligonucleotides is deemed to be 
approved.
                                 <all>